Clinical trial: An Open-Label Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-524164-37-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24338

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology